The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation

Table 4 Lesion reduction in neoadjuvant chemotherapy subgroups

	n	No residual disease	Residual disease	p	χ²
IA-NAC+ RS	40	11 (27.5%)	29 (72.5%)	0.033	4.557
IV-NAC+ RS	63	7 (11.1%)	56 (88.9%)

ISSN: 1477-7819